These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

201 related items for PubMed ID: 25677088

  • 1. Rac1 modification by an electrophilic 15-deoxy Δ(12,14)-prostaglandin J2 analog.
    Wall SB, Oh JY, Mitchell L, Laube AH, Campbell SL, Renfrow MB, Landar A.
    Redox Biol; 2015; 4():346-54. PubMed ID: 25677088
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. The permissive role of mitochondria in the induction of haem oxygenase-1 in endothelial cells.
    Ricart KC, Bolisetty S, Johnson MS, Perez J, Agarwal A, Murphy MP, Landar A.
    Biochem J; 2009 Apr 15; 419(2):427-36. PubMed ID: 19161347
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Accumulation of 15-deoxy-delta(12,14)-prostaglandin J2 adduct formation with Keap1 over time: effects on potency for intracellular antioxidant defence induction.
    Oh JY, Giles N, Landar A, Darley-Usmar V.
    Biochem J; 2008 Apr 15; 411(2):297-306. PubMed ID: 18237271
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Thioredoxin as a molecular target of cyclopentenone prostaglandins.
    Shibata T, Yamada T, Ishii T, Kumazawa S, Nakamura H, Masutani H, Yodoi J, Uchida K.
    J Biol Chem; 2003 Jul 11; 278(28):26046-54. PubMed ID: 12709421
    [Abstract] [Full Text] [Related]

  • 8. Inhibition of mitochondrial division through covalent modification of Drp1 protein by 15 deoxy-Delta(12,14)-prostaglandin J2.
    Mishra N, Kar R, Singha PK, Venkatachalam MA, McEwen DG, Saikumar P.
    Biochem Biophys Res Commun; 2010 Apr 23; 395(1):17-24. PubMed ID: 20307494
    [Abstract] [Full Text] [Related]

  • 9. Identification of novel protein targets for modification by 15-deoxy-Delta12,14-prostaglandin J2 in mesangial cells reveals multiple interactions with the cytoskeleton.
    Stamatakis K, Sánchez-Gómez FJ, Pérez-Sala D.
    J Am Soc Nephrol; 2006 Jan 23; 17(1):89-98. PubMed ID: 16291835
    [Abstract] [Full Text] [Related]

  • 10. Nrf2-mediated induction of cytoprotective enzymes by 15-deoxy-Delta12,14-prostaglandin J2 is attenuated by alkenal/one oxidoreductase.
    Yu X, Egner PA, Wakabayashi J, Wakabayashi N, Yamamoto M, Kensler TW.
    J Biol Chem; 2006 Sep 08; 281(36):26245-52. PubMed ID: 16857669
    [Abstract] [Full Text] [Related]

  • 11. Physiological and Pathological Roles of 15-Deoxy-Δ12,14-Prostaglandin J2 in the Central Nervous System and Neurological Diseases.
    Yagami T, Yamamoto Y, Koma H.
    Mol Neurobiol; 2018 Mar 08; 55(3):2227-2248. PubMed ID: 28299574
    [Abstract] [Full Text] [Related]

  • 12. 15-Deoxy-Delta(12,14)-prostaglandin J2: an electrophilic trigger of cellular responses.
    Uchida K, Shibata T.
    Chem Res Toxicol; 2008 Jan 08; 21(1):138-44. PubMed ID: 18052108
    [Abstract] [Full Text] [Related]

  • 13. Mitochondrial targeting of the electrophilic lipid 15-deoxy-Delta12,14-prostaglandin J2 increases apoptotic efficacy via redox cell signalling mechanisms.
    Diers AR, Higdon AN, Ricart KC, Johnson MS, Agarwal A, Kalyanaraman B, Landar A, Darley-Usmar VM.
    Biochem J; 2010 Jan 27; 426(1):31-41. PubMed ID: 19916962
    [Abstract] [Full Text] [Related]

  • 14. Electrophilic lipid mediator 15-deoxy-Δ12,14-prostaglandin j2 modifies glucocorticoid signaling via receptor SUMOylation.
    Paakinaho V, Kaikkonen S, Levonen AL, Palvimo JJ.
    Mol Cell Biol; 2014 Sep 27; 34(17):3202-13. PubMed ID: 24980431
    [Abstract] [Full Text] [Related]

  • 15. 15-Deoxy-Δ12,14-Prostaglandin J2 Modifies Components of the Proteasome and Inhibits Inflammatory Responses in Human Endothelial Cells.
    Marcone S, Evans P, Fitzgerald DJ.
    Front Immunol; 2016 Sep 27; 7():459. PubMed ID: 27833612
    [Abstract] [Full Text] [Related]

  • 16. MAP kinase phosphatase-1 expression is regulated by 15-deoxy-Δ12,14-prostaglandin J2 via a HuR-dependent post-transcriptional mechanism.
    Woo JH, Lee JH, Kim H, Choi Y, Park SM, Joe EH, Jou I.
    Biochim Biophys Acta; 2015 Jun 27; 1849(6):612-25. PubMed ID: 25805336
    [Abstract] [Full Text] [Related]

  • 17. 15-Deoxy-Δ12,14 -prostaglandin J2 binds and inactivates STAT3 via covalent modification of cysteine 259 in H-Ras-transformed human breast epithelial cells.
    Kim SJ, Cho NC, Han B, Kim K, Hahn YI, Kim KP, Suh YG, Choi BY, Na HK, Surh YJ.
    FEBS Lett; 2021 Mar 27; 595(5):604-622. PubMed ID: 33452674
    [Abstract] [Full Text] [Related]

  • 18. Modulation of mammary cancer cell migration by 15-deoxy-delta(12,14)-prostaglandin J(2): implications for anti-metastatic therapy.
    Diers AR, Dranka BP, Ricart KC, Oh JY, Johnson MS, Zhou F, Pallero MA, Bodenstine TM, Murphy-Ullrich JE, Welch DR, Landar A.
    Biochem J; 2010 Aug 15; 430(1):69-78. PubMed ID: 20536428
    [Abstract] [Full Text] [Related]

  • 19. Molecular basis for the direct inhibition of AP-1 DNA binding by 15-deoxy-Delta 12,14-prostaglandin J2.
    Pérez-Sala D, Cernuda-Morollón E, Cañada FJ.
    J Biol Chem; 2003 Dec 19; 278(51):51251-60. PubMed ID: 14532268
    [Abstract] [Full Text] [Related]

  • 20. 15-Deoxy-Δ(12,14)-prostaglandin J2 prevents oxidative injury by upregulating the expression of aldose reductase in vascular smooth muscle cells.
    Kang ES, Hwang JS, Ham SA, Park MH, Kim GH, Paek KS, Yoo T, Lee WJ, Kang KR, Lee JH, Choi YJ, Seo HG.
    Free Radic Res; 2014 Feb 19; 48(2):218-29. PubMed ID: 24180671
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.